Paper39394201
Synthesis of vitamin D3 loaded ethosomes gel to cure chronic immune-mediated inflammatory skin disease: physical characterization, in vitro and ex vivo studies.
Mehmood Y and 8 others. Sci Rep, 2024. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. Synthesis of vitamin D3 loaded ethosomes gel to cure chronic immune-mediated inflammatory skin disease: physical characterization, in vitro and ex vivo studies. Papers, record 39394201. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39394201
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Synthesis of vitamin D3 loaded ethosomes gel to cure chronic immune-mediated inflammatory skin disease: physical characterization, in vitro and ex vivo studies.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cholecalciferol | Major topic |
| Gels | Major topic |
| Animals | |
| Psoriasis | |
| Humans | |
| Particle Size | |
| Spectroscopy, Fourier Transform Infrared | |
| Liposomes | |
| Calorimetry, Differential Scanning | |
| Lecithins | |
| Skin | |
| Skin Absorption |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 39472630 | Author Correction: Synthesis of vitamin D3 loaded ethosomes gel to cure chronic immune-mediated inflammatory skin disease: physical characterization, in vitro and ex vivo studies. | https://conductscience.org/library/papers/39472630 |
Source PubMed
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36754285 | Nanobodies: Robust miniprotein binders in biomedicine. | Adv Drug Deliv Rev | 2023 | https://conductscience.org/library/papers/36754285 | PubMed |
| 2 | 22247870 | Spectrophotometric methods for the determination of letrozole in bulk and pharmaceutical dosage forms. | J Adv Pharm Technol Res | 2010 | https://conductscience.org/library/papers/22247870 | PubMed |
| 3 | 32679784 | Immunologic Effects of Vitamin D on Human Health and Disease. | Nutrients | 2020 | https://conductscience.org/library/papers/32679784 | PubMed |
| 4 | 36412870 | Developing of SiO2 Nanoshells Loaded with Fluticasone Propionate for Potential Nasal Drug Delivery: Determination of Pro-Inflammatory Cytokines through mRNA Expression. | J Funct Biomater | 2022 | https://conductscience.org/library/papers/36412870 | PubMed |
| 5 | 34532853 | The role of glucagon-like peptide 1 (GLP-1) in addictive disorders. | Br J Pharmacol | 2022 | https://conductscience.org/library/papers/34532853 | PubMed |
| 6 | 36467708 | Role of Nanozymes in Oral Cancer the Road Ahead. | Top Catal | 2022 | https://conductscience.org/library/papers/36467708 | PubMed |
| 7 | 36964440 | Sustained antigens delivery using composite microneedles for effective epicutaneous immunotherapy. | Drug Deliv Transl Res | 2023 | https://conductscience.org/library/papers/36964440 | PubMed |
| 8 | 25613837 | Carbon nanotubes part II: a remarkable carrier for drug and gene delivery. | Expert Opin Drug Deliv | 2015 | https://conductscience.org/library/papers/25613837 | PubMed |
| 9 | 36613602 | Lessons on Drug Development: A Literature Review of Challenges Faced in Nonalcoholic Fatty Liver Disease (NAFLD) Clinical Trials. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36613602 | PubMed |
| 10 | 36678668 | Preparation and Evaluation of Vitamin D3 Supplementation as Transdermal Film-Forming Solution. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/36678668 | PubMed |
| 11 | 36684440 | Designing of SiO2 mesoporous nanoparticles loaded with mometasone furoate for potential nasal drug delivery: Ex vivo evaluation and determination of pro-inflammatory interferon and interleukin mRNA expression. | Front Cell Dev Biol | 2022 | https://conductscience.org/library/papers/36684440 | PubMed |
| 12 | 34884710 | The Effects of Vitamin D on the Expression of IL-33 and Its Receptor ST2 in Skin Cells; Potential Implication for Psoriasis. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34884710 | PubMed |
| 13 | 33419149 | Oral Vitamin D Therapy in Patients with Psoriasis. | Nutrients | 2021 | https://conductscience.org/library/papers/33419149 | PubMed |
| 14 | 34335132 | Neuromodulation Management of Chronic Neuropathic Pain in The Central Nervous system. | Adv Funct Mater | 2020 | https://conductscience.org/library/papers/34335132 | PubMed |
| 15 | 32085884 | Disease modifying drugs for rheumatological diseases: a brief history of everything. | Adv Protein Chem Struct Biol | 2020 | https://conductscience.org/library/papers/32085884 | PubMed |
| 16 | 27987825 | A composite chitosan-gelatin bi-layered, biomimetic macroporous scaffold for blood vessel tissue engineering. | Carbohydr Polym | 2017 | https://conductscience.org/library/papers/27987825 | PubMed |
| 17 | 34067151 | Psoriasis: From Pathogenesis to Pharmacological and Nano-Technological-Based Therapeutics. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34067151 | PubMed |
| 18 | 34621269 | Macrophages Control the Bioavailability of Vitamin D and Vitamin D-Regulated T Cell Responses. | Front Immunol | 2021 | https://conductscience.org/library/papers/34621269 | PubMed |
| 19 | 37752779 | Antimicrobial Hydrogels: Potential Materials for Medical Application. | Small | 2024 | https://conductscience.org/library/papers/37752779 | PubMed |
| 20 | 28558147 | Safety and efficacy of a bioabsorbable fluticasone propionate-eluting sinus dressing in postoperative management of endoscopic sinus surgery: a randomized clinical trial. | Int Forum Allergy Rhinol | 2017 | https://conductscience.org/library/papers/28558147 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42658262 | Macrophage programming in systemic sclerosis: Niches, networks, and translational horizons. | Semin Immunopathol | 2026 | https://conductscience.org/library/papers/42658262 | PubMed |
| 42351101 | Ethosomal nanocarrier encapsulating curcumin for antimicrobial photodynamic therapy: efficacy analysis against mature Streptococcus mutans biofilm. | BMC Oral Health | 2026 | https://conductscience.org/library/papers/42351101 | PubMed |
| 41807739 | Nanocarriers, Smart Biomaterials and Emerging Therapeutics for Psoriasis: Current Progress and Future Directions. | AAPS PharmSciTech | 2026 | https://conductscience.org/library/papers/41807739 | PubMed |
| 41403744 | Decrypting the Potential of Lipidic Vesicular System for Delivery Enhancement of Tranexamic Acid in Melasma Hyperpigmentation Treatment. | Adv Pharm Bull | 2025 | https://conductscience.org/library/papers/41403744 | PubMed |
| 40766841 | Development and optimization of a novel nanocarrier SabiWhite-loaded ethosomal gel for targeted skin inflammation complicated by multidrug-resistant pathogens. | Front Cell Infect Microbiol | 2025 | https://conductscience.org/library/papers/40766841 | PubMed |
| 40691409 | Exploring the Therapeutic Potential of Lipid Nanocarriers in Psoriasis Management: Advances and Applications. | AAPS PharmSciTech | 2025 | https://conductscience.org/library/papers/40691409 | PubMed |
| 40430874 | Ethosome-Based Transdermal Drug Delivery: Its Structural Components, Preparation Techniques, and Therapeutic Applications Across Metabolic, Chronic, and Oncological Conditions. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40430874 | PubMed |
| 40422378 | Modified Phospholipid Vesicular Gel for Transdermal Drug Delivery: The Influence of Glycerin and/or Ethanol on Their Lipid Bilayer Fluidity and Penetration Characteristics. | Gels | 2025 | https://conductscience.org/library/papers/40422378 | PubMed |
| 40343291 | Fabrication and assessment of ethosomes for effective transdermal delivery of loxoprofen. | Iran J Basic Med Sci | 2025 | https://conductscience.org/library/papers/40343291 | PubMed |
| 39931531 | Development and Characterization of a Hydrogel Containing Chloramphenicol-Loaded Binary Ethosomes for Effective Transdermal Permeation and Treatment Acne in Rat Model. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/39931531 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39394201
GET https://conductscience.org/api/papers/v1/39394201/references?page=2